SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 651.81-0.3%3:59 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biotechwantabe who wrote (3485)1/10/2023 3:37:28 PM
From: Miljenko Zuanic1 Recommendation

Recommended By
Spekulatius

  Read Replies (1) of 3557
 
Did they cover story on Eylea 4Q sale decline blaming Avastin and copay?
Every year 4Q sale decline (relative to 3Q) due to copay draught out, but this much????
Is this "the end" of the honesty at REGN, after few years of reality (and prosperity) when events by itself asked for "true" (favorable) reporting????

I am REGN shareholder from 1996! , the day/year I started US equity speculations and bets!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News